CLBS - Caladrius Biosc Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (-0.13%) POLA (4.94%) OCGN (2.03%) MOXC (21.98%) MGNI (3.88%) GSAT (-4.84%) GRWG (4.3%) GOED (11.97%) GME (0%) FURY (0%) ETSY (0%) ENG (0%) CWH (0%) CRSR (0%) CPE (0%) CELH (0%) BZUN (0%) BFLY (-2.62%) BBIG (0%) BA (-0.09%) AVXL (0%) AU (0%) AMPUSD (%) AMC (0.06%) ABNB (1.27%)

CLBS - Caladrius Bioscience...

$1.57 0[0%]

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$1.57	Open
Volume	352	Market Cap	30.73M
Yield		Last Dividend

Day

52 Week

Caladrius Bio to assess CLBS201 in diabe...	06/22/21
No summary available.

Hedge Funds Are Buying Caladrius Bioscie...	06/21/21
No summary available.

Caladrius Biosciences to Present at Nobl...	06/17/21
Presentation begins today at 10:30 a.m. Eastern time Presentation begins today at 10:30 a.m. Eastern time

Caladrius Biosciences Announces Particip...	05/31/21
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (Caladrius or the Company), a clinical-stage biopharmaceutical company dedicated to the development of cell...

Caladrius Biosciences, Cassava Sciences ...	05/12/21
Caladrius Biosciences Inc (NASDAQ: CLBS ) has received $1.4 million in non-dilutive funding as an approved participant of the Technology Business Tax ...

Caladrius Biosciences Receives $1.4 Mill...	05/11/21
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease...

ANALYST RATINGS

1 analyst ratings (Last 3 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $CLBS

Service Name	Trader	% Success
Tech and Biotech Catalysts	Michael	43.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%